![Frédéric Jacotot](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frédéric Jacotot
General Counsel bei VALNEVA
Vermögen: 1 Mio $ am 31.05.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Franck Grimaud | M | 58 |
Vaccines Holdings Sweden AB
![]() Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014.
Valneva Austria GmbH
![]() Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013.
Valneva Sweden AB
![]() Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers. | 11 Jahre |
Thomas Lingelbach | M | 60 |
Valneva Austria GmbH
![]() Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013.
Valneva Sweden AB
![]() Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers.
Vaccines Holdings Sweden AB
![]() Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014. | 11 Jahre |
Wolfgang Bender | M | 70 |
Valneva Sweden AB
![]() Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers.
Valneva Austria GmbH
![]() Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013. | 7 Jahre |
David Lawrence | M | 61 |
Vaccines Holdings Sweden AB
![]() Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014.
Valneva Sweden AB
![]() Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers. | 7 Jahre |
Anne-Marie Graffin | F | 63 | 11 Jahre | |
Peter Buhler | M | 54 | 3 Jahre | |
Jim Connolly | M | 59 | 2 Jahre | |
Vincent Dequenne | M | - | 3 Jahre | |
James Sulat | M | 73 | 11 Jahre | |
Laetitia Bachelot-Fontaine | F | - | 11 Jahre | |
Juan Carlos Jaramillo | M | 53 | 4 Jahre | |
Kathrin Jansen | M | - | 1 Jahre | |
Lars Åke Gunnar Hallman | M | 82 |
Vaccines Holdings Sweden AB
![]() Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014. | 10 Jahre |
Joshua Drumm | M | - | - | |
Maïlys Ferrère | F | 60 | 2 Jahre | |
Reinhard Kandera | M | 54 |
Vaccines Holdings Sweden AB
![]() Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014. | - |
Dipal Patel | F | - | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Sharon Tetlow | F | 64 | 3 Jahre | |
Alexander Ullrich von Gabain | M | 73 | 7 Jahre | |
Sandra E. Poole | F | 60 | 3 Jahre | |
Ralf Clemens | M | 71 | 3 Jahre | |
Johanna Willemina Pattenier | M | 64 | 3 Jahre | |
Frédéric Grimaud | M | 59 | 11 Jahre | |
Thomas Casdagli | M | 47 | 2 Jahre | |
Klaus Schwamborn | M | - | 9 Jahre | |
Bali Muralidhar | M | 44 | 2 Jahre | |
Louisa Shaw-Marotto | F | 56 | 4 Jahre | |
Jeffrey Kent | M | 62 |
Abbott Laboratories, Inc.
![]() Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | 8 Jahre |
Perry Denis Celentano | M | - | - | |
Annette Matthies | M | 47 |
Abbott Laboratories, Inc.
![]() Abbott Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Inc., the company manufactures and wholesales diagnostic and pharmaceutical products as well as medical devices. The company is based in Chicago, IL. | 1 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Frankreich | 26 | 86,67% |
Schweden | 6 | 20,00% |
Österreich | 3 | 10,00% |
Vereinigte Staaten | 2 | 6,67% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Frédéric Jacotot
- Persönliches Netzwerk